4.6 Article

Heart failure and movement-induced hemodynamics: Partitioning the impact of central and peripheral dysfunction

期刊

INTERNATIONAL JOURNAL OF CARDIOLOGY
卷 178, 期 -, 页码 232-238

出版社

ELSEVIER IRELAND LTD
DOI: 10.1016/j.ijcard.2014.10.044

关键词

Passive exercise; Blood flow; Exercise pressor response; Afferents; Mechanoreflex

资金

  1. NIH [P01 HL-091830]
  2. VA [E6910R]
  3. Department of Veterans Affairs

向作者/读者索取更多资源

Background: The complex pathophysiology of heart failure (HF) creates a challenging paradigm to differentiate the role of central and peripheral hemodynamic dysfunction during conventional exercise. Adopting a novel reductionist approach with potential clinical relevance, we studied the central and peripheral contributors to both continuous and single passive leg movement (PLM)-induced hyperemia in 14 HF patients with reduced ejection fraction (HFrEF) and 13 controls. Methods: Heart rate (HR), stroke volume (SV), cardiac output (CO), mean arterial pressure (MAP), and femoral artery blood flow (FBF) were recorded during PLM. Results: The FBF response (area under the curve; AUC) to 60 s of continuous PLM was attenuated in the HFrEF (25 +/- 15 ml AUC) compared to controls (199 +/- 34 ml AUC) as were peak changes from baseline for FBF, leg vascular conductance (LVC), CO, and HR. During single PLM, increases in CO and HR were smaller and no longer different between groups, supporting the use of this modality to assess groups with disparate central hemodynamics. Interestingly, single PLM-induced hyperemia, likely predominantly driven by flow-mediated vasodilation due to minimal vessel deformation, was essentially nonexistent in the HFrEF (-9 +/- 10 ml AUC) in contrast to the controls (43 +/- 25 ml AUC). Conclusions: These data fail to support a HFrEF-associated exaggeration in the mechanoreceptor driven component of the exercise pressor response. In fact, by exhibiting limited central hemodynamic responses compared to the controls, the observed attenuation in movement-induced FBF in HFrEF appears largely due to peripheral vascular dysfunction, particularly flow-mediated vasodilation. Published by Elsevier Ireland Ltd.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Engineering, Biomedical

Risk of Renal Dysfunction Following Heart Transplantation in Patients Bridged with a Left Ventricular Assist Device

Anjan Tibrewala, Kiran K. Khush, Wida S. Cherikh, Julia Foutz, Josef Stehlik, Jonathan D. Rich

Summary: Acute renal failure (ARF) and chronic kidney disease (CKD) are associated with morbidity and mortality following heart transplantation (HT). This study found that patients with a left ventricular assist device (LVAD) have a higher incidence of ARF and CKD after HT compared to non-LVAD patients, but the incidence of CKD is similar by 3 years. Risk factors for ARF in LVAD patients include high body mass index (BMI), low baseline estimated glomerular filtration rate (eGFR), and long ischemic time. Risk factors for CKD in LVAD patients include high BMI, low baseline eGFR, pre-HT diabetes mellitus, and post-HT dialysis before discharge. These findings can help identify LVAD patients at risk for ARF and CKD after HT.

ASAIO JOURNAL (2022)

Article Cardiac & Cardiovascular Systems

Quantifying the Impact of Atrial Fibrillation on Heart Failure-Related Patient-Reported Outcomes in the Utah mEVAL Program

Benjamin A. Steinberg, Mingyuan Zhang, Jason Bensch, Ann Lyons, T. Jared Bunch, Jonathan P. Piccini, Alfonso Siu, John A. Spertus, Josef Stehlik, Peter Wohlfahrt, Tom Greene, Rachel Hess, James C. Fang

Summary: Atrial fibrillation (AF) frequently complicates heart failure (HF) and is associated with lower health-related quality of life. This study aimed to quantify the incremental burden of AF on the health-related quality of life of HF patients. The results showed that HF patients with AF had worse disease-specific and overall health-related quality of life compared to those with HF alone.

JOURNAL OF CARDIAC FAILURE (2022)

Article Cardiac & Cardiovascular Systems

A challenge to equity in transplantation: Increased center-level variation in short-term mechanical circulatory support use in the context of the updated US heart transplant allocation policy

Thomas M. Cascino, Josef Stehlik, Wida S. Cherikh, Yulin Cheng, Tessa M. F. Watt, Alexander A. Brescia, Michael P. Thompson, Jeffrey S. McCullough, Min Zhang, Supriya Shore, Jessica R. Golbus, Francis D. Pagani, Donald S. Likosky, Keith D. Aaronson

Summary: The United States National Organ Procurement Transplant Network implemented changes to improve access to heart transplantation for high-risk patients through the use of short-term mechanical circulatory support. The study found that the use of mechanical circulatory support increased after the policy changes, but there was also an increase in variability between different medical centers.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Editorial Material Cardiac & Cardiovascular Systems

Heart Xenotransplant: A Door That Is Finally Opening

Maryjane Farr, Josef Stehlik

CIRCULATION (2022)

Article Immunology

Fatal Allograft Rejection and Cardiac Allograft Vasculopathy After Treatment With Pembrolizumab for Metastatic Melanoma in a Heart Transplant Recipient: A Case Report

Jose Nativi-Nicolau, Josef Stehlik, Aaron J. Kelkhoff, Brian Khong, Crystal M. Truax, Monica P. Revelo, Edward Michael Gilbert, Stavros Drakos, Omar Wever-Pinzon, James Fang, Anna Catino, Hung T. Khong

Summary: This article reports a fatal rejection in a heart transplant recipient treated with pembrolizumab for metastatic melanoma, highlighting the limited experience and potential risks of immunosuppressed patients receiving checkpoint inhibitors.

TRANSPLANTATION PROCEEDINGS (2022)

Article Cardiac & Cardiovascular Systems

Right Heart Failure Following Left Ventricular Device Implantation: Natural History, Risk Factors, and Outcomes: An Analysis of the STS INTERMACS Database

Chris J. Kapelios, Lars H. Lund, Omar Wever-Pinzon, Craig H. Selzman, Susan L. Myers, Ryan S. Cantor, Josef Stehlik, Themistocles Chamogeorgakis, Stephen H. McKellar, Antigone Koliopoulou, Rami Alharethi, Abdallah G. Kfoury, Michael Bonios, Stamatis Adamopoulos, Edward M. Gilbert, James C. Fang, James K. Kirklin, Stavros G. Drakos

Summary: Right heart failure (RHF) after left ventricular assist device (LVAD) is a common and frequently transient condition, with de novo, late RHF (>6 months) being more frequently a persistent disorder associated with increased mortality. Several risk factors, such as higher preimplant blood urea nitrogen levels, previous tricuspid valve repair/replacement, severely depressed right ventricular systolic function, and centrifugal LVAD, are associated with an increased incidence of RHF. Patients with persistent RHF at 3 months have the lowest 2-year survival, while patients with de novo RHF or RHF that resolves by 3 months have more favorable survival outcomes.

CIRCULATION-HEART FAILURE (2022)

Article Surgery

Predicted heart mass for size matching in obese heart transplant donors and recipients

Natasha Aleksova, Chun-Po S. Fan, Farid Foroutan, Yas Moayedi, Juan Duero Posada, Caroline McGuinty, Adriana Luk, Josef Stehlik, Heather J. Ross, Ana C. Alba

Summary: This study evaluated the impact of size matching using actual heart mass and ideal heart mass on mortality and risk assessment in the obese population. The results showed that undersizing based on actual heart mass was associated with higher mortality rates, while no such association was observed with ideal heart mass.

CLINICAL TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

Epidemiology, risk factors, and outcomes of lung retransplantation: An analysis of the International Society for Heart and Lung Transplantation Thoracic Transplant Registry

Michael O. Harhay, Wida S. Cherikh, Alice E. Toll, Jason D. Christie, Josef Stehlik, Daniel Chambers, Don Hayes Jr, Edward Cantu

Summary: Lung retransplantation is a complex surgical decision that represents the only potential treatment option for recipients suffering from lung allograft failure. This study examined the modern landscape of lung retransplantation and found that the duration of time since the primary lung transplant was the strongest prognostic factor for 1-year mortality in retransplant recipients.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2022)

Article Cardiac & Cardiovascular Systems

Heart waitlist survival in adults with an intra-aortic balloon pump relative to other Status 2, Status 1, and inotrope Status 3 patients

Thomas C. Hanff, Adeline Browne, Jacqueline Dickey, Holly Gaines, Michael O. Harhay, Matt Goodwin, Craig H. Selzman, James C. Fang, Stavros G. Drakos, Josef Stehlik

Summary: Among Status 2 patients for heart transplantation, those supported with intra-aortic balloon pump (IABP) had lower risk of waitlist mortality compared to patients with ventricular tachycardia/fibrillation (VT/VF), right-or-biventricular assist device configurations, or temporary surgical left ventricular assist devices (LVADs).

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Rethinking Donor and Recipient Risk Matching in Europe and North America: Using Heart Transplant Predictors of Donor and Recipient Risk

Yasbanoo Moayedi, Eduard Rodenas-Alesina, Brigitte Mueller, Chun-Po S. Fan, Wida S. Cherikh, Josef Stehlik, Jeffrey J. Teuteberg, Heather J. Ross, Kiran K. Khush

Summary: European heart transplantation centers are more likely to accept higher-risk donor hearts than North American centers. The acceptance of higher-risk donor hearts is associated with higher survival rates in European centers.

CIRCULATION-HEART FAILURE (2023)

Article Surgery

Comparison of two donor-derived cell-free DNA tests and a blood gene-expression profile test in heart transplantation

Nicholas Rodgers, Bryn Gerding, Vincenzo Cusi, Florin Vaida, Yuko Tada, Gerald P. Morris, Eric D. Adler, Josef Stehlik, Paul J. Kim

Summary: This study compared the accuracy of two commercially available dd-cfDNA and gene-expression profiling (GEP) testing in detecting acute rejection (AR) in heart transplant recipients. The results showed that both standard and expanded SNP tests had low sensitivity but high specificity for AR, while GEP testing had worse specificity. Therefore, dd-cfDNA testing can be used as an alternative to GEP testing, with improved specificity without changing sensitivity.

CLINICAL TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

PROMIS: Physical, Mental and Social Health Outcomes Improve From Before to Early After LVAD Implant: Findings From the Mechanical Circulatory Support: Measures of Adjustment and Quality of Life (MCS A-QOL) Study

Elizabeth A. Hahn, Larry A. Allen, Christopher S. Lee, Quin E. Denfeld, Josef Stehlik, David Cella, Joann Lindenfeld, Jeffrey J. Teuteberg, Colleen K. Mcilvennan, Michael S. Kiernan, David G. Beiser, Mary N. Walsh, Eric D. Adler, Bernice Ruo, James K. Kirklin, Liviu Klein, Katy Bedjeti, Peter D. Cummings, James L. Burns, Alyssa M. Vela, Kathleen L. Grady

Summary: This study found that patients who received a left ventricular assist device (LVAD) experienced significant improvements in their physical, mental, and social health. These improvements were most pronounced in the first 3 months post-implantation.

JOURNAL OF CARDIAC FAILURE (2023)

Article Multidisciplinary Sciences

A machine learning model for prediction of 30-day primary graft failure after heart transplantation

Bjorn Linse, Mattias Ohlsson, Joseph Stehlik, Lars H. Lund, Bodil Andersson, Johan Nilsson

Summary: This study developed a model for predicting short-term mortality due to primary graft failure after heart transplantation using the ISHLT Heart Transplant Registry. The model identified underlying HF diagnosis, ischemia time, and sex as the most influential risk factors for PGF.

HELIYON (2023)

Article Cardiac & Cardiovascular Systems

The impact of obesity and LVAD-bridging on heart transplant candidate outcomes: a linked STS INTERMACS - OPTN/UNOS data analysis

Ana C. Alba, James K. Kirklin, Ryan S. Cantor, Luqin Deng, Heather J. Ross, Jeffrey P. Jacobs, Vivek Rao, Thomas C. Hanff, Josef Stehlik

Summary: This study compares the mortality outcomes of LVAD-bridged strategy and no LVAD in patients listed for heart transplant and post-transplant based on body mass index (BMI). The results show that LVAD-bridged candidates with obesity have a higher waitlist mortality compared to non-bridged candidates with obesity. Post-transplant mortality is similar in both LVAD-bridged and non-bridged patients, but obesity remains associated with increased mortality in both groups.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

Article Cardiac & Cardiovascular Systems

Left ventricular functional improvement appears to contribute to lower rates of device thrombosis in patients on durable mechanical circulatory support

Christos P. Kyriakopoulos, Benjamin D. Horne, Konstantinos Sideris, Iosif Taleb, Rachel J. Griffin, Eric Sheffield, Rami Alharethi, Thomas C. Hanff, Josef Stehlik, Craig H. Selzman, Stavros G. Drakos

Summary: By unloading the failing heart, LVADs create a favorable environment for reversing adverse cardiac changes. Improved native LV function may contribute to the risk of LVAD thrombosis. Our study found that LV functional improvement is associated with a lower risk of device thrombosis, whereas the risks of cerebrovascular accident and hemolysis were similar across LVAD LV function subgroups.

JOURNAL OF HEART AND LUNG TRANSPLANTATION (2023)

暂无数据